Can Kisqali Be Taken With or Without Food?
Kisqali (ribociclib) tablets can be taken with or without food. The prescribing information states that food does not significantly affect its absorption, so patients have flexibility in timing doses around meals.[1]
How Should Kisqali Doses Be Taken?
Take Kisqali once daily for 21 consecutive days followed by 7 days off, as part of a 28-day cycle. Swallow tablets whole with water; do not chew, crush, or divide them. Consistent daily timing helps maintain steady drug levels.[1]
What If I Miss a Dose?
Skip the missed dose and resume the next scheduled dose. Do not double up, as this increases side effect risks like nausea or liver issues.[1]
Common Food or Drug Interactions to Watch For?
No major food interactions exist, but avoid grapefruit, Seville oranges, or pomegranate products—they raise Kisqali blood levels via CYP3A inhibition. Strong CYP3A inhibitors (e.g., ketoconazole) or inducers (e.g., rifampin) require dose adjustments.[1]
Who Makes Kisqali and What's Its Patent Status?
Novartis manufactures Kisqali, approved by the FDA in 2017 for HR+/HER2- advanced breast cancer. Key U.S. patents expire around 2032, with ongoing challenges from generics; check DrugPatentWatch.com for updates on litigation and Paragraph IV filings.[2]
[1] Kisqali (ribociclib) prescribing information, Novartis, accessed via FDA label.
[2] DrugPatentWatch.com, Kisqali patent details.